Clinical Trial Update: Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pembrolizumab plus carboplatin versus carboplatin alone in breast cancer patients with chest wall involvement has completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Laura Huppert, MD, BA | Conditions: Breast Cancer, Chest Wall Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-12-22